 | • レポートコード：MRC2-11QY12166 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はB型肝炎ウイルス（HBV）のグローバル市場について調査・分析したレポートです。種類別（治療薬、ワクチン）市場規模、用途別（病院、外来手術センター、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別B型肝炎ウイルス（HBV）の競争状況、市場シェア ・世界のB型肝炎ウイルス（HBV）市場：種類別市場規模 2015年-2020年（治療薬、ワクチン） ・世界のB型肝炎ウイルス（HBV）市場：種類別市場規模予測 2021年-2026年（治療薬、ワクチン） ・世界のB型肝炎ウイルス（HBV）市場：用途別市場規模 2015年-2020年（病院、外来手術センター、診断センター） ・世界のB型肝炎ウイルス（HBV）市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、診断センター） ・北米のB型肝炎ウイルス（HBV）市場分析：米国、カナダ ・ヨーロッパのB型肝炎ウイルス（HBV）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのB型肝炎ウイルス（HBV）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のB型肝炎ウイルス（HBV）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのB型肝炎ウイルス（HBV）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck、Gilead Sciences、Novartis、GlaxoSmithKline、Hoffmann、La Roche、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
Among the type of treatment, therapeutics accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with chronic Hepatitis B virus with unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.
Market Analysis and Insights: Global Hepatitis B Vir (HBV) Market
The global Hepatitis B Vir (HBV) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Hepatitis B Vir (HBV) Scope and Market Size
Hepatitis B Vir (HBV) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B Vir (HBV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
…
Market segment by Type, the product can be split into
Therapeutics
Vaccine
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hepatitis B Vir (HBV) Revenue
1.4 Market by Type
1.4.1 Global Hepatitis B Vir (HBV) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Therapeutics
1.4.3 Vaccine
1.5 Market by Application
1.5.1 Global Hepatitis B Vir (HBV) Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B Vir (HBV) Market Perspective (2015-2026)
2.2 Global Hepatitis B Vir (HBV) Growth Trends by Regions
2.2.1 Hepatitis B Vir (HBV) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hepatitis B Vir (HBV) Historic Market Share by Regions (2015-2020)
2.2.3 Hepatitis B Vir (HBV) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hepatitis B Vir (HBV) Market Growth Strategy
2.3.6 Primary Interviews with Key Hepatitis B Vir (HBV) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B Vir (HBV) Players by Market Size
3.1.1 Global Top Hepatitis B Vir (HBV) Players by Revenue (2015-2020)
3.1.2 Global Hepatitis B Vir (HBV) Revenue Market Share by Players (2015-2020)
3.1.3 Global Hepatitis B Vir (HBV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hepatitis B Vir (HBV) Market Concentration Ratio
3.2.1 Global Hepatitis B Vir (HBV) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hepatitis B Vir (HBV) Revenue in 2019
3.3 Hepatitis B Vir (HBV) Key Players Head office and Area Served
3.4 Key Players Hepatitis B Vir (HBV) Product Solution and Service
3.5 Date of Enter into Hepatitis B Vir (HBV) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hepatitis B Vir (HBV) Historic Market Size by Type (2015-2020)
4.2 Global Hepatitis B Vir (HBV) Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
5.2 Global Hepatitis B Vir (HBV) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hepatitis B Vir (HBV) Market Size (2015-2020)
6.2 Hepatitis B Vir (HBV) Key Players in North America (2019-2020)
6.3 North America Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
6.4 North America Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hepatitis B Vir (HBV) Market Size (2015-2020)
7.2 Hepatitis B Vir (HBV) Key Players in Europe (2019-2020)
7.3 Europe Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
7.4 Europe Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
8 China
8.1 China Hepatitis B Vir (HBV) Market Size (2015-2020)
8.2 Hepatitis B Vir (HBV) Key Players in China (2019-2020)
8.3 China Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
8.4 China Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hepatitis B Vir (HBV) Market Size (2015-2020)
9.2 Hepatitis B Vir (HBV) Key Players in Japan (2019-2020)
9.3 Japan Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
9.4 Japan Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hepatitis B Vir (HBV) Market Size (2015-2020)
10.2 Hepatitis B Vir (HBV) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
10.4 Southeast Asia Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
11 India
11.1 India Hepatitis B Vir (HBV) Market Size (2015-2020)
11.2 Hepatitis B Vir (HBV) Key Players in India (2019-2020)
11.3 India Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
11.4 India Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hepatitis B Vir (HBV) Market Size (2015-2020)
12.2 Hepatitis B Vir (HBV) Key Players in Central & South America (2019-2020)
12.3 Central & South America Hepatitis B Vir (HBV) Market Size by Type (2015-2020)
12.4 Central & South America Hepatitis B Vir (HBV) Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Hepatitis B Vir (HBV) Introduction
13.1.4 Merck Revenue in Hepatitis B Vir (HBV) Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Gilead Sciences
13.2.1 Gilead Sciences Company Details
13.2.2 Gilead Sciences Business Overview
13.2.3 Gilead Sciences Hepatitis B Vir (HBV) Introduction
13.2.4 Gilead Sciences Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.2.5 Gilead Sciences Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Hepatitis B Vir (HBV) Introduction
13.3.4 Novartis Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Hepatitis B Vir (HBV) Introduction
13.4.4 GlaxoSmithKline Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Hoffmann
13.5.1 Hoffmann Company Details
13.5.2 Hoffmann Business Overview
13.5.3 Hoffmann Hepatitis B Vir (HBV) Introduction
13.5.4 Hoffmann Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.5.5 Hoffmann Recent Development
13.6 La Roche
13.6.1 La Roche Company Details
13.6.2 La Roche Business Overview
13.6.3 La Roche Hepatitis B Vir (HBV) Introduction
13.6.4 La Roche Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.6.5 La Roche Recent Development
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Details
13.7.2 Bristol-Myers Squibb Business Overview
13.7.3 Bristol-Myers Squibb Hepatitis B Vir (HBV) Introduction
13.7.4 Bristol-Myers Squibb Revenue in Hepatitis B Vir (HBV) Business (2015-2020)
13.7.5 Bristol-Myers Squibb Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hepatitis B Vir (HBV) Key Market Segments
Table 2. Key Players Covered: Ranking by Hepatitis B Vir (HBV) Revenue
Table 3. Ranking of Global Top Hepatitis B Vir (HBV) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hepatitis B Vir (HBV) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Therapeutics
Table 6. Key Players of Vaccine
Table 7. Global Hepatitis B Vir (HBV) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Hepatitis B Vir (HBV) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Hepatitis B Vir (HBV) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Hepatitis B Vir (HBV) Market Share by Regions (2015-2020)
Table 11. Global Hepatitis B Vir (HBV) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Hepatitis B Vir (HBV) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Hepatitis B Vir (HBV) Market Growth Strategy
Table 17. Main Points Interviewed from Key Hepatitis B Vir (HBV) Players
Table 18. Global Hepatitis B Vir (HBV) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Hepatitis B Vir (HBV) Market Share by Players (2015-2020)
Table 20. Global Top Hepatitis B Vir (HBV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vir (HBV) as of 2019)
Table 21. Global Hepatitis B Vir (HBV) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hepatitis B Vir (HBV) Product Solution and Service
Table 24. Date of Enter into Hepatitis B Vir (HBV) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Hepatitis B Vir (HBV) Market Size Share by Type (2015-2020)
Table 28. Global Hepatitis B Vir (HBV) Revenue Market Share by Type (2021-2026)
Table 29. Global Hepatitis B Vir (HBV) Market Size Share by Application (2015-2020)
Table 30. Global Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Hepatitis B Vir (HBV) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 34. North America Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 36. North America Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 38. Europe Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 40. Europe Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 42. Europe Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 44. China Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 46. China Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 47. China Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 48. China Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 49. China Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 50. Japan Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 52. Japan Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 54. Japan Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 58. Southeast Asia Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 60. Southeast Asia Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 62. India Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 64. India Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 65. India Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 66. India Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 67. India Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Hepatitis B Vir (HBV) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Hepatitis B Vir (HBV) Market Share (2019-2020)
Table 70. Central & South America Hepatitis B Vir (HBV) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Hepatitis B Vir (HBV) Market Share by Type (2015-2020)
Table 72. Central & South America Hepatitis B Vir (HBV) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Hepatitis B Vir (HBV) Market Share by Application (2015-2020)
Table 74. Merck Company Details
Table 75. Merck Business Overview
Table 76. Merck Product
Table 77. Merck Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 78. Merck Recent Development
Table 79. Gilead Sciences Company Details
Table 80. Gilead Sciences Business Overview
Table 81. Gilead Sciences Product
Table 82. Gilead Sciences Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 83. Gilead Sciences Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Product
Table 92. GlaxoSmithKline Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 93. GlaxoSmithKline Recent Development
Table 94. Hoffmann Company Details
Table 95. Hoffmann Business Overview
Table 96. Hoffmann Product
Table 97. Hoffmann Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 98. Hoffmann Recent Development
Table 99. La Roche Company Details
Table 100. La Roche Business Overview
Table 101. La Roche Product
Table 102. La Roche Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 103. La Roche Recent Development
Table 104. Bristol-Myers Squibb Company Details
Table 105. Bristol-Myers Squibb Business Overview
Table 106. Bristol-Myers Squibb Product
Table 107. Bristol-Myers Squibb Revenue in Hepatitis B Vir (HBV) Business (2015-2020) (Million US$)
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B Vir (HBV) Market Share by Type: 2020 VS 2026
Figure 2. Therapeutics Features
Figure 3. Vaccine Features
Figure 4. Global Hepatitis B Vir (HBV) Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Hepatitis B Vir (HBV) Report Years Considered
Figure 9. Global Hepatitis B Vir (HBV) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hepatitis B Vir (HBV) Market Share by Regions: 2020 VS 2026
Figure 11. Global Hepatitis B Vir (HBV) Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hepatitis B Vir (HBV) Market Share by Players in 2019
Figure 14. Global Top Hepatitis B Vir (HBV) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vir (HBV) as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis B Vir (HBV) Revenue in 2019
Figure 16. North America Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hepatitis B Vir (HBV) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
C型肝炎ウイルス（HCV）の世界市場（～2026年） Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chro…- E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…
- B型肝炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis B Therapeutics Market The global Hepatitis B Therapeutics market size is projected to reach US$ 2568.8 million by 2026, from US$ 2489 million in 2020, at a CAGR of 3.0%% during 2021-2026. Global Hepatitis B Therapeutics Scope and Market Size Hepatitis B…
- 肝炎診断検査の世界市場（～2026年） Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period.…
- 肝炎検査ソリューションの世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…